Skip to main content
Premium Trial:

Request an Annual Quote

Investment Bank Raises ABI's Stock Target

NEW YORK (GenomeWeb News) — Jefferies Broadview investment bank has raised the price target for Applied Biosystems’ shares to a $38 a share.
As GenomeWeb News reported yesterday, ABI said fiscal first quarter revenues increased 15 percent as profit turned to a loss.
The company also said expects to see “mid to high single digit revenue growth” for fiscal 2007. This outlook includes the full fiscal year impact from the March 2006 acquisition of Ambion and the impact of currency, ABI said.
The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.